journal1 ›› 2017, Vol. 25 ›› Issue (6): 637-638.DOI: 10.11852/zgetbjzz2017-25-06-29

• Orignal Article • Previous Articles     Next Articles

Observation of the impact of asthma children height and weight about small doses continuous inhaled corticosteroids 2 years

XU Zhi-qiang   

  1. Department of Pediatrics,Tongren Hospital,Medical College of Shanghai Jiaotong University,Shanghai 200336,China
  • Received:2016-09-20 Online:2017-06-10 Published:2017-06-10

小剂量持续性吸入糖皮质激素2年对哮喘小儿身高体重影响的观察

徐志强   

  1. 上海交通大学医学院附属同仁医院儿科,上海 200336
  • 作者简介:徐志强(1961-),男,副主任医师,主要研究方向为小儿过敏性疾病的防治。

Abstract: Objective To observe effects of small doses continuous inhaled corticosteroids on height and weight of the children with asthma,in order to provide the basis for specification of asthma treatment. Methods A total of 125 children with asthma performed the height and weight test for treatment with inhaled corticosteroids at 0.5,1,1.5,2 years.On height and weight in children with asthma was compared with normal children of Chinese city. Result There was no obvious difference on height and weight in children with asthma compared with normal children of Chinese city(P>0.05). Conclusions mall doses of persistent inhaled corticosteroide (ICS) does not affect children's growth.

Key words: corticosteroids, inhale, asthma, children, height, weight

摘要: 目的 观察小剂量持续性吸入糖皮质激素对哮喘患儿身高、体重的影响,为哮喘规范治疗提供依据。方法 随机抽取确诊为支气管哮喘的患儿125例,分别在治疗半年、治疗1年、治疗1年半及治疗2年时进行身高、体重测量,测量数据分别与中国城市同年龄健康儿童身高、体重进行比较。结果 患儿身高与中国城市同年龄健康儿童身高、体重进行比较,差异无统计学意义(P>0.05)。结论 小剂量持续性吸入皮质激素并不会影响儿童的生长发育。

关键词: 糖皮质激素, 吸入, 哮喘, 儿童, 身高, 体重

CLC Number: